Paydirt
JT
Insider

John Charles Thomas

EVP, General Counsel

John Charles Thomas (EVP, General Counsel) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Krystal Biotech, Inc. (KRYS). The largest single filing was $347K of KRYS (1,000 sh × $347.27, as filed), executed Jun 25.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$541K
shares × price, as filed
Last traded
Jun 25
Filed Jun 26

Median ADV $140.4M across their filed names

Open performance
Volume by month
$347K$174K$0Oct 2024Apr 2025Oct 2025Apr 2026May 2026 · sells $194KJun 2026 · sells $347K
Buys $0 Sells $541K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names
KRYS Krystal Biotech, Inc. KRYS · 0 buys · 2 sells 2 filings
Recent filings
KRYSSALE Krystal Biotech, Inc. View filing → $347K
1,000 sh × $347.27
Exec Jun 25
Filed Jun 26 · 5:30 PM ET
KRYSSALE Krystal Biotech, Inc. View filing → $194K
642 sh × $302.03
Exec May 26
Filed May 27 · 5:30 PM ET